RecruitingNot ApplicableNCT03417960

Accelerated iTBS for Post Partum Depression

An Open Label Study to Assess the Feasibility and Tolerability of Accelerated Theta Burst Repetitive Transcranial Magnetic Stimulation (iTBS-rTMS) for the Treatment of Post-Partum Depression


Sponsor

Medical University of South Carolina

Enrollment

40 participants

Start Date

Jan 24, 2018

Study Type

INTERVENTIONAL

Conditions

Summary

Study 1: The investigators are studying the feasibility and tolerability of 10x/day intermittent theta burst (excitatory) transcranial magnetic stimulation to the left dorsolateral prefrontal cortex over the course of 6 days for women with post-partum depression. The investigators further aim to characterize the anticipated anti-depressant effect of this treatment paradigm. Study 2: The investigators are studying the feasibility and tolerability of 12 sessions/day of intermittent theta burse (excitatory) transcranial magnetic stimulation to the left dorsolateral prefrontal cortex over 5 days for women with post-partum depression. The investigators aim to compare the two different treatment schedules.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 50 Years

Inclusion Criteria4

  • Participants must be able to provide informed consent and function at an intellectual level sufficient to allow accurate completion of all assessment instruments.
  • Participants must be over the age of 18.
  • Participants must meet criteria for post-partum depression: a) onset of symptoms in the first year postpartum
  • Participants must have a HRSD17 greater than or equal to 14 at baseline.

Exclusion Criteria8

  • Participants must not be pregnant.
  • Participants must not meet moderate or severe use disorder of any substance with the exception of Tobacco Use Disorder.
  • Participants must not have current psychotic symptoms.
  • Participants must not have a history of dementia or other cognitive impairment.
  • Participants must not have active suicidal ideation requiring hospitalization or a suicide attempt within the past 3 months.
  • Participants must not have any contraindications to receiving rTMS (e.g. metal implanted above the neck, history of seizure, any known brain lesion).
  • Participants must not have any unstable general medical conditions.
  • Participants must not have had eclampsia during pregnancy.

Interventions

DEVICEiTBS

The investigators will treat post-partum depressed subjects with accelerated intermittent theta burst stimulation. iTBS will be delivered via a MagVenture MagPro100 and Cool-B65 coil. The investigators will use a standard resting motor threshold (rMT) determination to determine the TMS dose. Treatment will be delivered at 120% of the motor threshold. In study 1, the accelerated paradigm will consist of 10 such sessions separated by 15 minutes, for three treatment days per week. There will be 2 weeks of 10 sessions on each of three days for a total of six treatment days, divided by one treatment-free week between treatment weeks. In study 2, the accelerated paradigm will consist of 12 sessions per day for 5 total treatment days. Treatments will be delivered at the 10-20 EEG coordinate for F3 (approximating the left DLPFC), and will be found using the Beam-F3 method.


Locations(1)

Medical University of South Carolina

Charleston, South Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03417960


Related Trials